Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease-Reference-Cited by-同舟云学术

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease

Published:2019-02-01 Issue:2 Volume:2 Page:e187800
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Artusi Carlo Alberto¹,Dwivedi Alok K.²,Romagnolo Alberto¹,Pal Gian³,Kauffman Marcelo⁴,Mata Ignacio⁵,Patel Dhiren⁶,Vizcarra Joaquin A.⁶,Duker Andrew⁶,Marsili Luca⁶,Cheeran Binith⁷⁸,Woo Daniel⁶,Contarino Maria Fiorella⁹¹⁰,Verhagen Leonard³,Lopiano Leonardo¹,Espay Alberto J.⁶,Fasano Alfonso¹¹¹²¹³,Merola Aristide⁶

Affiliation:

1. Department of Neuroscience Rita Levi Montalcini, University of Torino, Torino, Italy

2. Texas Tech University Health Sciences Center El Paso, El Paso

3. Rush University Medical Center, Chicago, Illinois

4. Consultorio de Neurogenética-Centro Universitario de Neurologia y Division Neurologia-Hospital J. M. Ramos Mejia-CONICET, Buenos Aires, Argentina

5. Genomic Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio

6. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio

7. Abbott Laboratories, Austin, Texas

8. The London Clinic, London, United Kingdom

9. Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands

10. Department of Neurology, Haga Teaching Hospital, The Hague, the Netherlands

11. Morton and Gloria Shulman Movement Disorders Clinic, Edmond J. Safra Program in Parkinson’s Disease, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

12. Division of Neurology, University of Toronto, Toronto, Ontario, Canada

13. Krembil Research Institute, Toronto, Ontario, Canada

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference63 articles.

1. GBA mutations and Parkinson disease: when genotype meets phenotype.;Scholz;Neurology,2015

2. Monogenic Parkinson’s disease and parkinsonism: clinical phenotypes and frequencies of known mutations.;Puschmann;Parkinsonism Relat Disord,2013

3. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease.;Obeso;N Engl J Med,2001

4. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease.;Zibetti;Mov Disord,2011

5. Long-term outcome of subthalamic nucleus DBS in Parkinson’s disease: from the advanced phase towards the late stage of the disease?;Rizzone;Parkinsonism Relat Disord,2014

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of diffusion changes in cerebral tissues of Parki̇nson's patients who underwent subthalamic nucleus deep brain stimulation: Correlation of improvements in motor and neuropsychiatric symptoms;Clinical Neurology and Neurosurgery;2024-09

2. Surgicogenomics: The Role of Genetics in Deep Brain Stimulation in Parkinson’s Disease Patients;Brain Sciences;2024-08-09

3. Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson's disease?;Parkinsonism & Related Disorders;2024-07

4. Parkinson’s Disease is Predominantly a Genetic Disease;Journal of Parkinson's Disease;2024-04-23

5. Advanced therapies in Parkinson’s disease: an individualized approach to their indication;Journal of Neural Transmission;2024-04-13